Daniel Budman

Title: The Innovations of Daniel Budman

Introduction

Daniel Budman is an accomplished inventor based in Locust Valley, NY (US). He has made significant contributions to the field of genomics, particularly in understanding drug resistance in cells. His work focuses on identifying genomic loci that play a crucial role in multiple drug resistance.

Latest Patents

Daniel Budman holds a patent for the invention titled "Identification of differentially methylated multiple drug resistance loci." This patent provides genomic loci that are hypermethylated and differentially expressed in drug-resistant cells compared to non-drug-resistant cells. The invention also includes nucleic acids isolated from these genomic loci using Methyl-Differential Display (MDD) methods. These nucleic acids are valuable for detecting mutations and methylation patterns, as well as for measuring the expression of mRNA from identified genes. The disclosed nucleic acids and their homologs are instrumental in inhibiting multiple drug resistance.

Career Highlights

Daniel Budman is associated with the North Shore-Long Island Jewish Research Institute, where he continues to advance research in drug resistance. His innovative work has the potential to impact therapeutic treatments significantly.

Collaborations

Daniel has collaborated with notable colleagues, including Hao-Peng Xu Duffy and Ji-dong Shan, contributing to a rich environment of research and innovation.

Conclusion

Daniel Budman's contributions to the field of genomics and drug resistance highlight the importance of innovation in medical research. His patent and ongoing work at the North Shore-Long Island Jewish Research Institute pave the way for future advancements in therapeutic treatments.